Document is current
Any future updates will be listed below
-
Authors
Farrens, Andria J.
Reinsdorf, Dylan
Garcia-Fernandez, Luis
Rojas, Raymond Diaz
Chan, Vicky
Perry, Joel
Wolbrecht, Eric T.
Reinkensmeyer, David J.
-
Funding
Funding for this research was provided by:
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
National Institutes of Health (NCT04818073)
- License Information
-
More Information
Article History
Received: 24 December 2024
Accepted: 10 June 2025
First Online: 18 July 2025
Declarations
:
: All participants provided informed consent (UCI IRB#476), and procedures were conducted according to the Declaration of Helsinki. The trial was registered on ClinicalTrials.Gov (NCT04818073).
: Not applicable.
: Dr. David Reinkensmeyer has financial interest (stock and consulting) in Hocoma and Flint Rehabilitation, both rehabilitation device companies.
